Stockreport

BBOT to Participate in Upcoming December Investor Healthcare Conferences

BridgeBio Oncology Therapeutics, Inc.  (BBOT) 
PDF SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical compan [Read more]